We are live on ! Find out more
MPA

Marvin & Palmer Associates Portfolio holdings

AUM $83.5M
1-Year Est. Return 77.51%
This Fund
S&P 500
This Quarter Est. Return
-7.03%
1 Year Est. Return
+77.51%
3 Year Est. Return
+274.35%
5 Year Est. Return
+527.21%
10 Year Est. Return
+3,503.66%
AUM
$116M
AUM Growth
-$15.8M
Cap. Flow
-$5.49M
Cap. Flow %
-4.73%
Top 10 Hldgs %
51.85%
Holding
36
New
10
Increased
14
Reduced
3
Closed
9

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$4.9M
2
LLY icon
Eli Lilly
LLY
+$4.86M
3
DIS icon
Walt Disney
DIS
+$4.84M
4
PFE icon
Pfizer
PFE
+$4.82M
5
ECL icon
Ecolab
ECL
+$4.41M

Sector Composition

Rank Sector Weight
1 Financials 31.23%
2 Healthcare 21.71%
3 Technology 15.94%
4 Consumer Discretionary 6.48%
5 Communication Services 4.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLV icon
1
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
$8.19M 7.05%
94,619
+1,904
+2% +$172K
CME icon
2
CME Group
CME
$96.3B
$7.55M 6.51%
40,145
-1,660
-4% -$307K
PYPL icon
3
PayPal
PYPL
$48.9B
$7.44M 6.41%
88,508
+2,439
+3% +$203K
MSFT icon
4
Microsoft
MSFT
$3.45T
$5.88M 5.06%
57,867
+6,157
+12% +$660K
TMO icon
5
Thermo Fisher Scientific
TMO
$213B
$5.44M 4.68%
24,300
+5,087
+26% +$1.19M
V icon
6
Visa
V
$684B
$5.4M 4.65%
40,930
+1,013
+3% +$140K
ADBE icon
7
Adobe
ADBE
$99.5B
$5.2M 4.48%
23,000
+561
+3% +$135K
MRK icon
8
Merck
MRK
$322B
$5.06M 4.36%
+69,411
New +$4.9M
LLY icon
9
Eli Lilly
LLY
$1.02T
$5.03M 4.33%
+43,467
New +$4.86M
TXN icon
10
Texas Instruments
TXN
$252B
$5M 4.31%
52,909
+1,491
+3% +$144K
JPM icon
11
JPMorgan Chase
JPM
$935B
$4.97M 4.28%
50,883
+1,231
+2% +$131K
UNH icon
12
UnitedHealth
UNH
$376B
$4.86M 4.19%
19,511
+3,413
+21% +$902K
PFE icon
13
Pfizer
PFE
$143B
$4.81M 4.14%
+116,078
New +$4.82M
DIS icon
14
Walt Disney
DIS
$167B
$4.67M 4.02%
+42,569
New +$4.84M
HD icon
15
Home Depot
HD
$331B
$4.6M 3.96%
26,753
+655
+3% +$117K
UNP icon
16
Union Pacific
UNP
$174B
$4.31M 3.71%
31,196
+731
+2% +$108K
ECL icon
17
Ecolab
ECL
$78.1B
$4.26M 3.67%
+28,900
New +$4.41M
BX icon
18
Blackstone
BX
$102B
$4.16M 3.58%
139,394
+3,212
+2% +$106K
AXP icon
19
American Express
AXP
$227B
$3.97M 3.42%
+41,635
New +$4.36M
VHT icon
20
Vanguard Health Care ETF
VHT
$18.1B
$3.36M 2.89%
20,905
+630
+3% +$107K
MCD icon
21
McDonald's
MCD
$192B
$2.92M 2.52%
+16,460
New +$2.92M
AMTD
22
DELISTED
TD Ameritrade Holding Corp
AMTD
$2.77M 2.39%
56,581
-7,860
-12% -$400K
AAPL icon
23
Apple
AAPL
$4.54T
$2.42M 2.09%
61,480
-40,740
-40% -$1.98M
EWZ icon
24
iShares MSCI Brazil ETF
EWZ
$9.28B
$1.01M 0.87%
+26,330
New +$1.02M
THD icon
25
iShares MSCI Thailand ETF
THD
$369M
$957K 0.82%
+11,555
New +$1M

Similar funds

Marvin & Palmer Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Marvin & Palmer Associates held 36 positions worth $116M, down 12% from $132M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Marvin & Palmer Associates withdrew a net $5.49M in Q4 2018, closing 9 positions and reducing 3 holdings. Its most notable exit was iShares Core S&P Small-Cap ETF, an estimated $8.77M position sold in full.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Marvin & Palmer Associates opened a new position in Merck worth $5.06M.

  • Marvin & Palmer Associates's largest Q4 2018 buy was Merck: 69,411 shares worth $5.06M.
  • Marvin & Palmer Associates added most to Thermo Fisher Scientific in Q4 2018, an estimated $1.19M increase.
  • Marvin & Palmer Associates's biggest Q4 2018 reduction was Apple, cutting an estimated $1.98M.
  • Marvin & Palmer Associates fully exited iShares Core S&P Small-Cap ETF in Q4 2018, selling an estimated $8.77M.
  • Marvin & Palmer Associates's ten largest holdings make up 52% of its $116M portfolio in Q4 2018.
  • Marvin & Palmer Associates opened 10 new positions and closed 9 in Q4 2018.
  • Marvin & Palmer Associates's portfolio value fell 12% quarter-over-quarter to $116M.

Based on Marvin & Palmer Associates's 13F filing for Q4 2018, filed 12 Feb 2019.